Medicine manufacturer Vietnam — healthcare is ultimately about people.

As a medicine manufacturer in Vietnam, VINPHACO understands that our connection with healthcare extends beyond pharmaceutical manufacturing.

On July 27, Vietnam observes War Invalids and Martyrs’ Day, a national occasion to remember and honour those who sacrificed and contributed to the country’s independence and development. The day carries deep historical and social significance in Vietnam.

In 2026, VINPHACO marked the occasion through a community healthcare programme carried out in cooperation with Vinh Phuc General Hospital and the People’s Committee of Lien Chau Commune.

The programme provided free medical examinations, health consultations and medicines for war veterans, wounded soldiers and families of those who sacrificed their lives for the country. In addition, 200 care packages were presented to local beneficiaries.

For VINPHACO, the programme reflects a broader connection between pharmaceutical manufacturing, healthcare and responsibility to the communities in which the company operates.

Table of Contents

• Community Healthcare as Part of Pharmaceutical Responsibility
• A Local Partnership Supporting Direct Healthcare Access
• Why Community Healthcare Matters to a Pharmaceutical Manufacturer
• More Than Manufacturing: People, Healthcare and Responsibility
• VINPHACO’s Long-Term Connection with Healthcare
• A Practical Perspective for International Partners

Community Healthcare as part of medicine manufacturer Vietnam’s Responsibility

For a medicine manufacturer in Vietnam, responsibility to healthcare does not stop at the production facility.

Pharmaceutical manufacturing is ultimately connected to people. Medicines are developed, manufactured, distributed and used because they contribute to healthcare systems and, ultimately, to patient care.

That broader perspective is one reason community healthcare initiatives remain meaningful for pharmaceutical companies.

VINPHACO’s July 27 programme combined several elements:

• Free medical examinations
• Health consultations
• Medicine distribution
• Support for war veterans and other eligible local beneficiaries
• 200 care packages for participants

The programme was therefore centred on direct healthcare support rather than simply a ceremonial activity.

The initiative also reflected the importance of collaboration. Medical professionals, local authorities and the pharmaceutical sector each contributed to the delivery of the programme.

A Local Partnership Supporting Direct Healthcare Access

The programme brought together three local partners: VINPHACO, Vinh Phuc General Hospital and the People’s Committee of Lien Chau Commune.

Each organisation contributed from a different position.

The hospital provided medical expertise through examinations and health consultations. The local authority supported community coordination and helped connect the programme with the intended beneficiaries. VINPHACO contributed to the healthcare programme through medicines and care packages.

This type of cooperation illustrates an important principle in community healthcare: meaningful support often requires more than one organisation.

Healthcare needs are diverse, and effective community programmes may depend on the combined contribution of healthcare professionals, local organisations, pharmaceutical companies and the communities themselves.

For VINPHACO, the connection is also geographically meaningful. The company has more than 66 years of development in Vietnam, while its current manufacturing and distribution activities serve healthcare needs both domestically and internationally.

Why Community Healthcare Matters to a Pharmaceutical Manufacturer

When international partners evaluate a pharmaceutical manufacturer in Vietnam, their attention naturally focuses on manufacturing-related considerations.

These may include:

• Manufacturing capabilities
• GMP and quality systems
• Product portfolio
• Regulatory requirements
• Supply capability
• Technical communication
• Export experience
• Long-term business cooperation

These factors are essential.

However, the organisation behind a pharmaceutical product also matters.

A pharmaceutical manufacturer is made up not only of production lines and facilities, but also of people, systems and organisational values.

Community healthcare activities provide one way of seeing how a company understands its broader role in the healthcare ecosystem.

This should not be interpreted as evidence that a community programme itself proves manufacturing quality or supply reliability. Those areas require their own evidence, systems and performance records.

Rather, community engagement provides another perspective on the organisation and the values it chooses to demonstrate through its activities.

More Than Manufacturing: People, Healthcare and Responsibility

The pharmaceutical industry is sometimes viewed primarily through products and manufacturing technology.

In reality, the healthcare ecosystem is much broader.

Behind a pharmaceutical product are professionals working across different functions, including:

• Research and development
• Quality assurance
• Quality control
• Manufacturing
• Engineering
• Regulatory affairs
• Supply chain
• Procurement
• Commercial and international business functions

These teams contribute in different ways to bringing pharmaceutical products into healthcare systems.

The same principle can be seen in community healthcare activities.

A successful programme requires coordination between organisations and people with different responsibilities and areas of expertise.

From this perspective, corporate responsibility is not separate from the healthcare industry. It is another way for organisations to participate in the wider environment in which healthcare takes place.

VINPHACO’s Long-Term Connection with Healthcare

VINPHACO was established in 1959 and has developed for more than six decades within Vietnam’s pharmaceutical industry. The company profile records milestones including the development of injectable manufacturing and subsequent investment in pharmaceutical manufacturing technologies and production systems.

Today, the company profile describes a manufacturing system that includes sterile production facilities, BFS manufacturing and non-sterile pharmaceutical production. The listed capabilities include solution injectable and infusion products, lyophilized injectables, aerosols, BFS products such as injectables and ophthalmic products, as well as tablets, capsules, liquids, powders and granules.

VINPHACO also maintains an international presence. According to the current company profile, nearly 100 products are marketed in more than 20 countries, alongside domestic distribution through hospitals, healthcare facilities, private clinics and pharmacies.

This combination of domestic healthcare engagement and international pharmaceutical activity provides an important context for understanding the company’s role.

The objective of pharmaceutical manufacturing is ultimately connected to healthcare — whether products are supplied to a local healthcare facility or to an international market.

A Practical Perspective for International Partners

For international pharmaceutical partners, choosing a manufacturer involves more than comparing product lists and prices.

Long-term cooperation can involve discussions about:

• Product quality
• Manufacturing capabilities
• GMP requirements
• Regulatory documentation
• Product registration
• Supply planning
• Technical communication
• Quality expectations
• Problem solving
• Long-term cooperation

These are practical aspects of pharmaceutical business development.

But behind these discussions are organisations and people.

A manufacturer needs systems capable of supporting pharmaceutical production, while international cooperation also requires communication, responsibility and the ability to work across different functions and markets.

Community healthcare initiatives cannot replace evidence of manufacturing capability, regulatory compliance or product quality. They are not intended to.

They can, however, provide a different perspective on the organisation behind the products.

For VINPHACO, the July 27 community healthcare programme was an opportunity to contribute directly to local healthcare while remembering the people whose sacrifices are honoured on War Invalids and Martyrs’ Day.

For the broader pharmaceutical industry, it is also a reminder that medicines ultimately exist for people.

Looking Beyond the Factory

Pharmaceutical manufacturing is an important part of healthcare, but it is only one part of a much larger system.

A company’s role can extend from manufacturing facilities and quality systems to partnerships, healthcare support and engagement with the communities around it.

VINPHACO’s July 27 programme brought these dimensions together in a practical way: healthcare professionals provided medical services, local authorities helped coordinate the community, and VINPHACO contributed medicines and care packages.

For an organisation working in pharmaceuticals, these connections matter.

Quality manufacturing, responsible business practices and community engagement are different areas, and each should be assessed on its own evidence. Together, however, they help provide a broader view of the people and organisation behind a pharmaceutical manufacturer in Vietnam.